Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for cognitive dysfunction in breast cancer survivors
NCT01466270Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of donepezil in cognitive disorder (CD), sponsored by Wake Forest University Health Sciences. Started Jul 2012; status: completed.
02
Drugs
donepezil
03
Conditions
cognitive disorder (CD)
Beyond the preview
Go deeper on NCT01466270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466270.